Cargando…

Antimalarial Activity of Ethyl Acetate Extract and Fraction of Bidens pilosa against Plasmodium berghei (ANKA)

BACKGROUND: Malaria is one of the most critical diseases causing about 219 million cases worldwide in developing countries. The spread and development of resistance against chemical antimalarial drugs is one of the major problems associated with malaria control. The present study was to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Nadia, Noumedem Anangmo Christelle, Cédric, Yamssi, Raoul, Simeni Njonnou Sylvain, Christian, Ngongang Ouankou, Azizi, Mounvera Abdel, Diane, Gangueu Djape Clotilde, Nkouayep, Vanessa Rosine, Jeanette, Yondo, Gabriel, Tsila Henri, Mbida, Mpoame
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502121/
https://www.ncbi.nlm.nih.gov/pubmed/32963817
http://dx.doi.org/10.1155/2020/8832724
_version_ 1783584158593843200
author Nadia, Noumedem Anangmo Christelle
Cédric, Yamssi
Raoul, Simeni Njonnou Sylvain
Christian, Ngongang Ouankou
Azizi, Mounvera Abdel
Diane, Gangueu Djape Clotilde
Nkouayep, Vanessa Rosine
Jeanette, Yondo
Gabriel, Tsila Henri
Mbida, Mpoame
author_facet Nadia, Noumedem Anangmo Christelle
Cédric, Yamssi
Raoul, Simeni Njonnou Sylvain
Christian, Ngongang Ouankou
Azizi, Mounvera Abdel
Diane, Gangueu Djape Clotilde
Nkouayep, Vanessa Rosine
Jeanette, Yondo
Gabriel, Tsila Henri
Mbida, Mpoame
author_sort Nadia, Noumedem Anangmo Christelle
collection PubMed
description BACKGROUND: Malaria is one of the most critical diseases causing about 219 million cases worldwide in developing countries. The spread and development of resistance against chemical antimalarial drugs is one of the major problems associated with malaria control. The present study was to investigate the antimalarial efficacy of ethyl acetate extract and one fraction of Bidens pilosa in vivo in order to support the usage of this plant by traditional healers to treat malaria. METHODS: The extracts were prepared by maceration of B. pilosa leaf powder in ethyl acetate. The liquid filtrate of the extract and the best in vitro antiplasmodial fraction using HPLC were concentrated and evaporated using a rotavapor under vacuum to dryness. The antimalarial activity of B. pilosa plant products were evaluated in vivo against Plasmodium berghei infected mice according to the Peter and Rane test. The antimalarial efficacy of the a selected crude extract (ethyl acetate extract) was evaluated at 125, 250, and 500 mg/kg, while a selected fraction from ethyl acetate extract (fraction 12) was evaluated at 62.5 and 125 mg/kg. Blood from experimental animals was collected to assess hematological parameters. RESULTS: The crude extract of ethyl acetate and fraction 12 demonstrated 100% in vivo parasite suppressive activity at doses of 500 mg/kg and 125 mg/kg, respectively, for the crude extract and fraction 12. The mice treated with 250 and 500 mg/kg had their parasitemia (intraerythrocytic phase of P. Berghei) drop considerably, disappearing by the 8(th) day in mice receiving 500 mg/kg. The ethyl acetate extract of B. pilosa, fraction 12 showed an even higher antiplasmodial activity. By the 5(th) day of the experiment, the treatment led to a modification of hematological parameters in mice. The chloroquine (5 mg/kg), fraction 12 (125 mg/kg), and the crude extract (500 mg/kg) groups all survived the 30 days of the experiment, while the negative control group registered 100% of the deaths. CONCLUSION: This study scientifically supports the use of Bidens pilosa leaves in the traditional treatment of malaria. However, the mode of action and in vivo toxicity of the plant still need to be assessed.
format Online
Article
Text
id pubmed-7502121
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-75021212020-09-21 Antimalarial Activity of Ethyl Acetate Extract and Fraction of Bidens pilosa against Plasmodium berghei (ANKA) Nadia, Noumedem Anangmo Christelle Cédric, Yamssi Raoul, Simeni Njonnou Sylvain Christian, Ngongang Ouankou Azizi, Mounvera Abdel Diane, Gangueu Djape Clotilde Nkouayep, Vanessa Rosine Jeanette, Yondo Gabriel, Tsila Henri Mbida, Mpoame J Parasitol Res Research Article BACKGROUND: Malaria is one of the most critical diseases causing about 219 million cases worldwide in developing countries. The spread and development of resistance against chemical antimalarial drugs is one of the major problems associated with malaria control. The present study was to investigate the antimalarial efficacy of ethyl acetate extract and one fraction of Bidens pilosa in vivo in order to support the usage of this plant by traditional healers to treat malaria. METHODS: The extracts were prepared by maceration of B. pilosa leaf powder in ethyl acetate. The liquid filtrate of the extract and the best in vitro antiplasmodial fraction using HPLC were concentrated and evaporated using a rotavapor under vacuum to dryness. The antimalarial activity of B. pilosa plant products were evaluated in vivo against Plasmodium berghei infected mice according to the Peter and Rane test. The antimalarial efficacy of the a selected crude extract (ethyl acetate extract) was evaluated at 125, 250, and 500 mg/kg, while a selected fraction from ethyl acetate extract (fraction 12) was evaluated at 62.5 and 125 mg/kg. Blood from experimental animals was collected to assess hematological parameters. RESULTS: The crude extract of ethyl acetate and fraction 12 demonstrated 100% in vivo parasite suppressive activity at doses of 500 mg/kg and 125 mg/kg, respectively, for the crude extract and fraction 12. The mice treated with 250 and 500 mg/kg had their parasitemia (intraerythrocytic phase of P. Berghei) drop considerably, disappearing by the 8(th) day in mice receiving 500 mg/kg. The ethyl acetate extract of B. pilosa, fraction 12 showed an even higher antiplasmodial activity. By the 5(th) day of the experiment, the treatment led to a modification of hematological parameters in mice. The chloroquine (5 mg/kg), fraction 12 (125 mg/kg), and the crude extract (500 mg/kg) groups all survived the 30 days of the experiment, while the negative control group registered 100% of the deaths. CONCLUSION: This study scientifically supports the use of Bidens pilosa leaves in the traditional treatment of malaria. However, the mode of action and in vivo toxicity of the plant still need to be assessed. Hindawi 2020-09-11 /pmc/articles/PMC7502121/ /pubmed/32963817 http://dx.doi.org/10.1155/2020/8832724 Text en Copyright © 2020 Noumedem Anangmo Christelle Nadia et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nadia, Noumedem Anangmo Christelle
Cédric, Yamssi
Raoul, Simeni Njonnou Sylvain
Christian, Ngongang Ouankou
Azizi, Mounvera Abdel
Diane, Gangueu Djape Clotilde
Nkouayep, Vanessa Rosine
Jeanette, Yondo
Gabriel, Tsila Henri
Mbida, Mpoame
Antimalarial Activity of Ethyl Acetate Extract and Fraction of Bidens pilosa against Plasmodium berghei (ANKA)
title Antimalarial Activity of Ethyl Acetate Extract and Fraction of Bidens pilosa against Plasmodium berghei (ANKA)
title_full Antimalarial Activity of Ethyl Acetate Extract and Fraction of Bidens pilosa against Plasmodium berghei (ANKA)
title_fullStr Antimalarial Activity of Ethyl Acetate Extract and Fraction of Bidens pilosa against Plasmodium berghei (ANKA)
title_full_unstemmed Antimalarial Activity of Ethyl Acetate Extract and Fraction of Bidens pilosa against Plasmodium berghei (ANKA)
title_short Antimalarial Activity of Ethyl Acetate Extract and Fraction of Bidens pilosa against Plasmodium berghei (ANKA)
title_sort antimalarial activity of ethyl acetate extract and fraction of bidens pilosa against plasmodium berghei (anka)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502121/
https://www.ncbi.nlm.nih.gov/pubmed/32963817
http://dx.doi.org/10.1155/2020/8832724
work_keys_str_mv AT nadianoumedemanangmochristelle antimalarialactivityofethylacetateextractandfractionofbidenspilosaagainstplasmodiumbergheianka
AT cedricyamssi antimalarialactivityofethylacetateextractandfractionofbidenspilosaagainstplasmodiumbergheianka
AT raoulsimeninjonnousylvain antimalarialactivityofethylacetateextractandfractionofbidenspilosaagainstplasmodiumbergheianka
AT christianngongangouankou antimalarialactivityofethylacetateextractandfractionofbidenspilosaagainstplasmodiumbergheianka
AT azizimounveraabdel antimalarialactivityofethylacetateextractandfractionofbidenspilosaagainstplasmodiumbergheianka
AT dianegangueudjapeclotilde antimalarialactivityofethylacetateextractandfractionofbidenspilosaagainstplasmodiumbergheianka
AT nkouayepvanessarosine antimalarialactivityofethylacetateextractandfractionofbidenspilosaagainstplasmodiumbergheianka
AT jeanetteyondo antimalarialactivityofethylacetateextractandfractionofbidenspilosaagainstplasmodiumbergheianka
AT gabrieltsilahenri antimalarialactivityofethylacetateextractandfractionofbidenspilosaagainstplasmodiumbergheianka
AT mbidampoame antimalarialactivityofethylacetateextractandfractionofbidenspilosaagainstplasmodiumbergheianka